Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration
Jo Jewell, Director, Head of Social Responsibility Partnerships at Novo Nordisk, shared on LinkedIn:
”We’re excited to see the Novartis Foundation and Novo Nordisk join forces to tackle cardiometabolic risk in cities.
Our new collaboration will combine insights and proven approaches from the two leading urban health programmes CARDIO 4 Cities (Novartis Foundation and Cities for Better Health (Novo Nordisk).
Initially launching in two European capitals, the goal is to build scalable models using practical tools, real-time data and catalytic funding to scale prevention and strengthen health systems in many more cities.
By working together, our collaboration has the potential to create lasting impact on urban health and social inequities.
Learn more:

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization